ACSL4 inhibitor |
Triacsin C, troglitazone, rosiglitazone |
[374–376] |
ALOX inhibitor |
Zileuton, MK886, PD146176, baicalein, LOXBlock-1 |
[33, 42, 45, 377, 378] |
DPP4 inhibitor |
Vildagliptin, alogliptin, linagliptin |
[30, 360] |
Iron chelator |
Deferoxamine (DFO), 2,2-bipyridyl, ciclopirox olamine (CPX), deferiprone, pioglitazone |
[9, 324, 379, 380] |
Lipid peroxidation inhibitor |
Ferrostatins (e.g., ferrostatin-1, SRS11-92, SRS12-45, SRS13-35, SRS13-37, and SRS16-86), liproxstatin-1 |
[9, 45] |
Lysosome and autophagy inhibitor |
Ammonium chloride, bafilomycin A1, chloroquine, wortmannin, 3-methyladenine, cryptotanshinone, CA-074Me, pepstatin A, E64 |
[381–385] |
Mitochondrial ROS inhibitor |
XJB-5–131, JP4-039, mitoTEMPO, MitoQ |
[226, 386, 387] |
NOX inhibitor |
2-acetylphenothiazine, diphenyleneiodonium chloride (DPI) |
[9, 30] |
Broad-spectrum antioxidant |
Vitamin E, vitamin K, n-acetylcysteine (NAC), butylated hydroxyltoluene (BHT), GSH and CoQ10
|
[9, 108, 388–390] |
FDFT1 inhibitor |
Zaragozic acid A, YM-53,601 |
[40] |
STING1 inhibitor |
H-151 |
[355] |
CTSB inhibitor |
CA-074Me |
[181] |